Diagnostics, Biosciences Tools Drive BD's 18 Percent Sales Spike in Q1 | GenomeWeb
NEW YORK (GenomeWeb News) — Becton Dickinson today said that its fiscal first-quarter revenues rose 13 percent as R&D spending increased 14.5 percent and its profit nearly doubled.
 
Total revenues for the three months ended Dec. 31, 2007, increased to $1.7 billion from $1.5 billion year over year. Currency effects contributed roughly 6 percent of the revenue growth, the firm said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.